Literature DB >> 22050563

Lifetime visual prognosis of patients with glaucoma.

Yi Wei Goh1, Ghee Soon Ang, Augusto Azuara-Blanco.   

Abstract

BACKGROUND: To investigate the visual outcome of glaucoma patients.
DESIGN: This is a retrospective study of case notes of patients who died while under follow up in a glaucoma clinic of a University Hospital in Scotland between 2006 and 2009. PARTICIPANTS: Seventy-seven patients were identified.
METHODS: Data collected included type of glaucoma, coexisting pathology and best-corrected visual acuity in Snellen (converted to decimal values) for the first and final clinic visit. The final visual status was evaluated based on the best-corrected visual acuity of the better seeing eye at the last glaucoma clinic visit. Patients who had best-corrected visual acuity of less than Snellen decimal 0.5 were considered not to meet the standards for driving. MAIN OUTCOME MEASURES: Snellen decimal best-corrected visual acuity, fulfilment of driving standards, and eligibility for partial sight and blind registration at the last clinic visit.
RESULTS: The mean ages at presentation and death were 71.8 ± 10.3 years and 82.2 ± 8.7 years respectively. The mean Snellen decimal best-corrected visual acuity of the better eye at presentation was 0.78, and at the final clinic visit was 0.61. At the final clinic visit, no patients were partial sight registrable, four (5.2%) were blind registrable, and 27 (35.1%) did not fulfil UK driving criteria. Glaucoma patients with other ocular pathologies were more likely to fail UK driving criteria at presentation (P = 0.02) and at last clinic visit (P = 0.03).
CONCLUSION: The majority of glaucoma patients maintained good visual function at the end of their lifetime.
© 2011 The Authors. Clinical and Experimental Ophthalmology © 2011 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Mesh:

Year:  2011        PMID: 22050563     DOI: 10.1111/j.1442-9071.2011.02559.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  4 in total

1.  A view on glaucoma--are we seeing it clearly?

Authors:  D P Crabb
Journal:  Eye (Lond)       Date:  2015-11-27       Impact factor: 3.775

Review 2.  Eye Movement Abnormalities in Glaucoma Patients: A Review.

Authors:  Matthew A McDonald; Clark H Stevenson; Hannah M Kersten; Helen V Danesh-Meyer
Journal:  Eye Brain       Date:  2022-09-08

Review 3.  How do different lighting conditions affect the vision and quality of life of people with glaucoma? A systematic review.

Authors:  Jamie Enoch; Lee Jones; Deanna J Taylor; Carol Bronze; James F Kirwan; Pete R Jones; David P Crabb
Journal:  Eye (Lond)       Date:  2019-12-10       Impact factor: 3.775

4.  Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol.

Authors:  Anthony J King; Gordon Fernie; Augusto Azuara-Blanco; Jennifer M Burr; Ted Garway-Heath; John M Sparrow; Luke Vale; Jemma Hudson; Graeme MacLennan; Alison McDonald; Keith Barton; John Norrie
Journal:  Br J Ophthalmol       Date:  2017-10-26       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.